Nephrology Times
Advertisement
Lupin's generic tolvaptan tablets are now FDA-approved for treating autosomal dominant polycystic kidney disease (ADPKD).
We spoke to David M. Hume Award winner Bradley Warady, MD, at the National Kidney Foundation Spring Clinical Meetings 2025.
Joel Topf spoke to onconephrologist Meghan Sise about her carboplatin dosing research at SCM25.
Joel Topf caught up with James Tumlin at NKF SCM25 to talk about Dr. Tumlin's late-breaking abstract on sparsentan in FSGS.
This Freely Filtered episode discusses REGENCY, examining the efficacy and safety of obinutuzumab in active lupus nephritis.
Joel Topf spoke with Lazarus Award winner Jeffrey Perl at the National Kidney Foundation Spring Clinical Meetings 2025.
Joel Topf spoke with Connie Rhee at SCM25 about her study on cognitive function with dialysis vs conservative CKD management.
Joel Topf spoke with Bradley Marder of Amgen about gout studies at the NKF Spring Clinical Meetings 2025.
A survey sought insight on nephrologists' practices and perceptions about reproductive care for women with kidney disease.
Joel Topf spoke to Excellence in Transplantation Award winner Jayme Locke at the National Kidney Foundation SCM25.
A study examined the effects of SGLT2i on eGFR slope in patients with autosomal dominant polycystic kidney disease.
Tonix Pharmaceuticals and Makana Therapeutics will collaborate on preclinical xenotransplantation research and development.
The FDA has granted Priority Review to pegcetacoplan to treat C3 glomerulopathy and primary IC-MPGN.
Researchers at SCM25 presented interim results of the SPARTAN trial of sparsentan as a treatment for patients with IgAN.
Dr. Daryl Crenshaw gave a detailed review of the significance of the APOL1 gene at the NephCure 2025 Patient Summit.
At the NephCure Patient Summit, Montrez Lucas presented a session on how people with kidney disease can navigate insurance.
Dr. Purva Sharma educated patients with kidney disease about clinical trials in a NephCure 2025 Patient Summit session.
Social worker Janay Thompson shared mental health tips for patients with kidney disease at the NephCure 2025 Patient Summit.
Dr. Thomas Pham spoke to us about kidney donation during National Donate Life Month.
One-year results of the AFFINITY trial of atrasentan to treat proteinuria among patients with IgAN were presented at SCM25.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.